Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
The Evolution of Personalized Care: Navigating Mechanisms of Biologic Therapies
Grand Hyatt Washington
1000 H Street NW
Washington, D.C., USA, 20001
Tel: +1 202 582 1234
The Registration and Information Desk at the Washington, DC Grand Hyatt, Independence Ballroom A will be staffed:
Sunday, May 17, 2015
6:15 pm – 8:30 pm
Registration is complimentary. Please remember to bring your DDWTM Badge.
Available seating will be based on room capacity. Seating is limited and pre-registration does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating will be first come first serve until capacity is met.
Continuing Medical Education
Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex®, LLC designates this live educational activity for a maximum 1.5 of AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other health-care professionals (physicians-in-training,
nurses, pharmacists, physicians’ assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.
After successful completion of this activity, participants should be better able to:
- Assess the mechanisms of disease involved in the pathogenesis of IBD
- Relate the mechanism of action of new and emerging agents to the pathogenesis of IBD
- For an individual patient, explain the goals of treatment and selected approaches for deliveringIBD care
- Evaluate the risk and benefits of current and emerging therapies for IBD
- Plan strategies to overcome common IBD disease management challenges
Maria T. Abreu, MD
Miller School of Medicine
University of Miami
Stephen B. Hanauer, MD, FACG, AGAF
Northwestern Feinberg School of Medicine
David T. Rubin, MD, FACG, AGAF
University of Chicago Medicine
Miguel Reguiero, MD, FACG
University of Pittsburgh
Welcome & Pre-Activity Survey via Audience Response
Navigating Mechanisms of Biologic Therapies
Case-Based Debate: Optimization of Biologic Therapy for the Management of IBD
• Proactive Therapeutic Approach vs ReactiveTherapeutic Approach
• Clinical Treatment Algorithms for IBD
• Step-Up versus Top-Down Management
• Therapeutic Drug Monitoring
• Switching of Biologics
• Risk Benefit Equation
• Shared Decision-Making Process (Optimization of Physician/Patient Interaction)
Faculty Consensus on Biologic Therapies: What’s the Verdict?
Faculty panel moderated by chair
Closing Remarks, Recap of Key Messages & Post-Activity
Survey via ARS
Supported by an educational grant from
Takeda Pharmaceuticals International, Inc. U.S. Region
All slide presentations will be available to view on the electronic device of your choice—laptop, tablet, smart phone, etc., via Array technology*. This is the most convenient way to provide attendees with the most up-to-date information. A book of printed presentations is not available; we encourage you to use your electronic device during the conference for optimal participation.
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334